Semaglutide in the UK: Why There Is No Ampule — and What the Pen Actually Delivers

Step 1, Understanding why the word 'ampule' appears, and what semaglutide actually comes in

An ampule is a sealed glass or plastic vessel used in clinical and compounding settings to store a measured quantity of liquid medicine. Semaglutide prescribed for weight loss in the UK does not come in that form. Wegovy (the brand licensed here for weight management) arrives as a pre-filled injection pen made by Novo Nordisk. The solution inside is already at the correct concentration, the dose dial is pre-set, and the needle attaches to the pen tip. Nothing is drawn up. Nothing is mixed. You press the pen against the skin, press the button, and the dose is delivered.

This matters for safety. Ampule-based medicines require clinical training to handle correctly: measuring volume, avoiding air bubbles, and disposing of used syringes. A pre-filled pen removes those steps entirely, which is one reason regulators in the UK approved this delivery format for patient self-administration at home. If you want to understand more about how semaglutide works as a medicine, including its mechanism and clinical background, our dedicated page covers it in full. If you have come across a seller advertising semaglutide in vials or ampules, that is a red flag, the licensed UK product does not exist in that format, and the MHRA has warned publicly about fake and unlicensed weight-loss injectables circulating online.

The full Wegovy overview on our site covers the pen format, storage requirements and what to expect from each strength.

Step 2, What the licensed UK pen range looks like, from starter dose to maximum

Wegovy's UK titration schedule is set by the prescriber, not chosen by the patient. The standard route starts at 0.25 mg once weekly, then steps through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose, with roughly four weeks at each level. The pace is deliberate: moving too quickly increases the chance of nausea, vomiting and other gastrointestinal symptoms that are the most common side effects of this class of medicine.

In April 2026 the MHRA approved a dedicated single-dose 7.2 mg pen, a higher maintenance dose for adults with a BMI of 30 or above. The MHRA's announcement on GOV.UK confirms this pen has a built-in covered needle, auto-dosing mechanism and locks after use. Even at this higher dose, treatment still begins at 0.25 mg, the 7.2 mg level is reached after the same step-by-step titration, guided by a prescriber throughout.

Each pen in the standard range contains four weekly doses, so one pen covers one month of treatment at a stable dose. For a closer look at semaglutide at the 2 mg level, including how it fits into the titration journey, our page explains what patients can expect at that stage. Storage for all versions is refrigerated (2–8°C); check the patient information leaflet for the specific room-temperature window if you need to travel.

If you want to understand how individual dose strengths are used in practice, the 1 mg semaglutide page walks through one step in that journey.

Step 3, The prescription process and why a clinical assessment comes first

Semaglutide for weight management is a Prescription-Only Medicine. That means a clinician must assess your health history, current medications and BMI before a prescription can be written, there is no legitimate route to this medicine without that step. The NHS offers semaglutide via specialist weight management services under NICE guidance (TA875), but waiting times can be long and the eligibility criteria are specific.

A private route through a registered online pharmacy moves faster, provided the pharmacy is properly regulated. The quick check that takes under a minute: search the pharmacy's name or registration number on the GPhC pharmacy register, every legitimate UK online pharmacy appears there. If it does not, do not order from it.

At nume, every consultation is read by a GPhC-registered Independent Prescriber on the day it is submitted. Your identity is verified with photo ID, and weight is confirmed on a live video call. If the assessment is completed before midday on a working day, treatment is dispatched the same day for free next-working-day delivery via DPD, in plain packaging. For anyone wondering about the cost side of things, the Wegovy cost page sets out what affects private pricing in the UK.

A broader look at weight-loss treatment options may also help if you are still deciding which medicine to ask about.

Side effects and what to watch for during titration

The most commonly reported side effects of semaglutide are gastrointestinal: nausea, loose stools, constipation, indigestion and, for some people, vomiting. These tend to be most noticeable in the days after a dose increase and often settle as the body adjusts. Eating smaller meals, avoiding high-fat foods and staying well hydrated reduces their severity for most people.

Rarely, more serious effects can occur. Acute pancreatitis (severe, persistent pain in the upper abdomen that may spread to the back, with or without vomiting) requires prompt medical attention. The NHS semaglutide medicine page lists symptoms to take seriously and when to seek urgent help. Other signs that warrant contacting a doctor include symptoms suggesting gallbladder problems, significant dehydration from prolonged vomiting or diarrhoea, or any allergic reaction.

Semaglutide carries a Black Triangle (▼) designation in the UK, meaning the MHRA continues to collect data on its long-term safety profile. Reporting side effects through the Yellow Card scheme at yellowcard.mhra.gov.uk contributes to that monitoring and helps protect future patients. Some people also ask whether the medicine affects sleep, if that is a concern, our page on whether Wegovy can cause sleeplessness addresses it directly.

If you have read this far and think semaglutide might suit you, the right next step is a clinical conversation. Start your free consultation with our prescribers, they will read your answers the same day and let you know whether treatment is clinically appropriate for you.